GEORGE CLINICAL, INC.
OVERLAND PARK, KS

Who is George Clinical? – Marisa Petersen Tell us, who is George Clinical? 0:05 – 0:24 George Clinical is a full service CRO that has a unique set of experience and also footprint in the Asia-Pacific region. We include India in the Asia-Pacific region because traditionally it has been one of our largest and most successfully units in the business. How is George Clinical different from their competitors? 0:25 – 1:07 Scientific Leadership is an offering that we have in George Clinical that is quite different, I think, to any other CRO. All studies have clinical leaders, we know that, but the relationship between the researchers and the sites that we involve in our region is quite different. We engage the scientific leaders from the start of the study, study design, selection of sites and motivation throughout the study. This enables us to continue to engage with the sites on a peer to peer level between those scientific leaders and the investigators; it has benefits in terms of patient recruitment and patient retention, and we believe this something that really differentiates us. How can we find out more about George Clinical? 2:58 – 3:17 Download our latest brochure to see how we can help you deliver clinical trial excellence from design to delivery. Headquartered in Sydney, Australia; George Clinical is located in China, India, Hong Kong, Taiwan, South Korea, Malaysia, New Zealand, United Kingdom, Czech Republic and the United States. We provide services in the majority of countries in the Asia-Pacific region including Japan, Korea, Singapore, Philippines, Sri Lanka, Bangladesh, Thailand and Indonesia. A successful trial begins with a solid foundation that focuses on site selection and strategies to achieve maximum enrolment. George Clinical utilizes their scientific leaders, world-leading experts in chronic disease and oncology, to assist in the recruitment of key investigators for complex, early-phase programs. George Clinical’s focus on peer-to-peer interaction allows for a clearer understanding of our programs, allowing earlier buy-in and commitment. George Clinical offers a full range of services for Phase I-II clinical trials including study design, protocol development, medical oversight from practicing clinicians, site monitoring, regulatory affairs, database development, and statistics and data management. In the US, George Clinical has access to a proprietary technology tool, Site Tracking and Recruitment (STAR) that automates the site feasibility process by matching investigators from our database from over 700 community and academic sites with trial-specific requirements. This technology combined with George Clinical‘s site start up expertise and project leadership provides the foundation necessary to achieve trial objectives. George Clinical is headquartered in Australia and has considerable experience managing studies at excellent Phase I Units in Australia, utilising the streamline regulatory notification scheme and advising on the generous tax refund available for R&D activities. George Clinical are experts at helping sponsors balance the complex demands associated with real-world or late-phase trials – protecting patient safety, designing clinically relevant studies, implementing simplified study techniques, building exposure to international clinical practice in chronic disease and oncology and producing evidence to maximize commercial opportunities. George Clinical has spent many years developing enviable investigator networks across the world’s most populous region – the Asia Pacific region. George Clinical has embarked on a campaign to utilise these networks (which span across a variety of therapeutic disciplines) to significantly enhance the quantity and quality of data generated across a broad spectrum of chronic deisease and oncology related studies. Together with executive leaders who have built and led late-stage trials for over 15 years, this makes George Clinical the ideal partner for real world research. George Clinical combines scientific and operational excellence to deliver exceptional patient recruitment, retention and project quality at a competitive cost. George Clinical offers scientific engagement and leadership above and beyond the conventional contract research organisation helping you make a greater impact with your trial. The George Institute’s mission is to improve the health of millions of people worldwide by creating scientific impact and effecting real change in medical practice and policy. Their work in real world clinical settings paves the way for George Clinical to design and deliver clinical trials aimed at meeting unmet clinical needs. Together we have: This model combines the industry standard efficiency in operations and timelines with scientific engagement to provide our sponsors with the best of both worlds. Download our latest brochure to see how we can help you deliver clinical trial excellence from design to delivery. George Clinical’s senior management team bring together unique and innovative qualities that make us a key partner in clinical research programs. Our team combines significant scientific and medical knowledge as well as the operational expertise developed through decades of working in clinical research, pharmaceutical companies, medical device companies and CROs. Chief Executive Officer, George Clinical Marisa completed her pharmacy degree at the University of Sydney and continued her studies with a PhD in Clinical Pharmacology and Pharmacokinetics. She has worked for over 20 years in the pharmaceutical industry, fulfilling roles in Regulatory Affairs, Clinical Research and Project Management. Prior to joining George Clinical, Marisa was the Vice President Asia Pacific for Omnicare Clinical Research, a global CRO, taking responsibility for the delivery of trials in the Asia-Pacific region and developing a network of offices across the region to effectively service customer needs. In her current role, Marisa is focussed on sustainable growth of resources in the region and delivery of regional and global studies to the highest international standards. Marisa has a strong association with ARCS in Australia and Asia and is a member of the Australian R&D Taskforce.